On July 15, Iluvatar CoreX rose 8.1% in regular trading, trading at HK$528.0/share, with turnover of HK$259 million. The stock rebounded strongly after briefly falling below its placement price of HK$476 on July 14.

On the news front, multiple international investment banks recently initiated coverage on the company with buy ratings. Bank of America Securities assigned a Buy rating with a target price of HK$1,013, projecting revenue CAGR of 145% from 2025 to 2028 and an adjusted net profit turnaround by 2026. Macquarie gave an Outperform rating with a target of HK$1,240, citing the company's leading position in domestic GPGPU development. JP Morgan raised its target price to HK$920 with an Overweight rating.

The company completed a placement of 14.857 million new H shares on July 13 at HK$476 per share, representing a 15% discount, raising net proceeds of approximately HK$7.034 billion. Following the placement, short-term dilution concerns had driven shares below the offering price, but the concentrated bullish coverage from major brokerages has helped restore market confidence.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)